Literature DB >> 4281990

Glycogenosis type II (Pompe). The fourth autopsy case in Japan.

I Sakurai, A Tosaka, Y Mori, S Imura, K Aoki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4281990     DOI： 10.1111/j.1440-1827.1974.tb00851.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN： 0001-6632


× No keyword cloud information.
  8 in total

Review 1.  Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.

Authors:  Marianne Rohrbach; Joe T R Clarke
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease.

Authors:  Loren D M Pena; Alan D Proia; Priya S Kishnani
Journal:  JIMD Rep       Date:  2015-03-13

Review 3.  Liver depot gene therapy for Pompe disease.

Authors:  Priya S Kishnani; Dwight D Koeberl
Journal:  Ann Transl Med       Date:  2019-07

4.  CRIM-negative infantile Pompe disease: 42-month treatment outcome.

Authors:  Marianne Rohrbach; Andrea Klein; Alice Köhli-Wiesner; Dorothe Veraguth; Ianina Scheer; Christian Balmer; Roger Lauener; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2010-09-30       Impact factor: 4.982

5.  Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy.

Authors:  Paul T McIntosh; Lisa D Hobson-Webb; Zoheb B Kazi; Sean N Prater; Suhrad G Banugaria; Stephanie Austin; Raymond Wang; David S Enterline; Donald P Frush; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2017-10-13       Impact factor: 4.797

6.  The emerging phenotype of long-term survivors with infantile Pompe disease.

Authors:  Sean N Prater; Suhrad G Banugaria; Stephanie M DeArmey; Eleanor G Botha; Erin M Stege; Laura E Case; Harrison N Jones; Chanika Phornphutkul; Raymond Y Wang; Sarah P Young; Priya S Kishnani
Journal:  Genet Med       Date:  2012-04-26       Impact factor: 8.822

7.  Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy.

Authors:  C M van Gelder; C I van Capelle; B J Ebbink; I Moor-van Nugteren; J M P van den Hout; M M Hakkesteegt; P A van Doorn; I F M de Coo; A J J Reuser; H H W de Gier; A T van der Ploeg
Journal:  J Inherit Metab Dis       Date:  2011-10-19       Impact factor: 4.982

8.  A review of treatment of Pompe disease in infants.

Authors:  Yin-Hsiu Chien; Wuh-Liang Hwu
Journal:  Biologics       Date:  2007-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.